Development of Machine Learning Regression Model for COVID-19 Drug Target Prediction

Alexandra Zamitalo, Qingtong Xie, Mayar Allam, Phinu Philip, Wenqi Shi, Felipe O. Giuste, Benoit Marteau, Mio Murakoso, May D. Wang

Abstract

There is a perennial need to identify novel, effective therapeutic agents to combat rising infections. Recently, prediction of therapeutic targets to decrease the impact of COVID-19 has posed an urgent challenge requiring innovative solutions. Successful identification of novel drug-target combinations may greatly facilitate drug development. To meet this need, we developed a COVID-19 drug target prediction model using machine learning approaches to quickly identify drug candidates for 18 COVID-19 protein targets. Specifically, we analyzed the performance of three prediction models to predict drug-target docking scores, which represents the strength of interactions between ligands and proteins. Docking scores were predicted for 300,457 molecules on 18 different COVID-19 related protein docking targets. Our proposed approach achieved a competitive performance with $\mathrm{R}^{2}$=0.69,MAE=0.285, MSE=0.627. In addition, we identify chemical structures associated with stronger binding affinities across target binding sites. We believe our work could potentially save pharmaceutical companies significant resources, especially during the early stages of drug development.
BibTeX
@inproceedings{zamitalo2022development,
  author = {Alexandra Zamitalo and Qingtong Xie and Mayar Allam and Phinu Philip and Wenqi Shi and Felipe O. Giuste and Benoit Marteau and Mio Murakoso and May D. Wang},
  title = {{Development of Machine Learning Regression Model for COVID-19 Drug Target Prediction}},
  booktitle = {BIBM},
  year = {2022},
  doi = {10.1109/bibm55620.2022.9995319},
}

Loading related content...

Figure